Apolipoprotein E, Statins, and Risk of Intracerebral Hemorrhage

Apolipoprotein E (ApoE) genotypes have been associated with lobar intracerebral hemorrhage (ICH). Although statins have been associated with an increased risk of ICH, meta-analyses have not consistently shown a statin-induced risk of ICH. Here, we test whether hypercholesterolemia (HC) and ApoE poly...

Full description

Saved in:
Bibliographic Details
Published inStroke (1970) Vol. 44; no. 11; pp. 3013 - 3017
Main Authors Woo, Daniel, Deka, Ranjan, Falcone, Guido J., Flaherty, Matthew L., Haverbusch, Mary, Martini, Sharyl R., Greenberg, Steven M., Ayres, Alison M., Sauerbeck, Laura, Kissela, Brett M., Kleindorfer, Dawn O., Moomaw, Charles J., Anderson, Christopher D., Broderick, Joseph P., Rosand, Jonathan, Langefeld, Carl D., Woo, Jessica G.
Format Journal Article
LanguageEnglish
Published Hagerstown, MD Lippincott Williams & Wilkins 01.11.2013
Subjects
Online AccessGet full text
ISSN0039-2499
1524-4628
1524-4628
DOI10.1161/STROKEAHA.113.001304

Cover

Loading…
Abstract Apolipoprotein E (ApoE) genotypes have been associated with lobar intracerebral hemorrhage (ICH). Although statins have been associated with an increased risk of ICH, meta-analyses have not consistently shown a statin-induced risk of ICH. Here, we test whether hypercholesterolemia (HC) and ApoE polymorphisms affect the risk of ICH by statin use. The Genetic and Environmental Risk Factors for Hemorrhagic Stroke (GERFHS) study is a prospective, demographically matched case-control study of ICH. A similar study of ICH, Genetic Risks for Medication-Related Hemorrhagic Stroke (GOCHA), was used as a replication cohort. Subjects were classified as normocholesterolemia, HC without statin use, and HC with statin use. Statistical comparisons were performed using Fisher exact test, χ2 tests, and the Breslow-Day test. The discovery cohort consisted of 558 ICH cases and 1444 controls, and the replication cohort consisted of 1020 ICH cases and 382 controls. The association of lower risk for HC was not attenuated by statin use. Statin use was observed to confer a higher risk for lobar ICH in those carrying ApoE4/E4 and ApoE2/E4 genotypes in both discovery and replication cohorts, and a test for interaction showed a trend towards significance (P=0.11 for statin and ApoE4/E4). Statin use does not seem to attenuate the association of HC with decreased risk for nonlobar ICH. Our data support a gene-by-drug effect for lobar ICH, but larger sample sizes are needed to confirm the association before any clinical change is warranted. http://clinicaltrials.gov. Unique identifier: NCT00930280.
AbstractList Apolipoprotein E (ApoE) genotypes have been associated with lobar intracerebral hemorrhage (ICH). Although statins have been associated with an increased risk of ICH, meta-analyses have not consistently shown a statin-induced risk of ICH. Here, we test whether hypercholesterolemia (HC) and ApoE polymorphisms affect the risk of ICH by statin use. The Genetic and Environmental Risk Factors for Hemorrhagic Stroke (GERFHS) study is a prospective, demographically matched case-control study of ICH. A similar study of ICH, Genetic Risks for Medication-Related Hemorrhagic Stroke (GOCHA), was used as a replication cohort. Subjects were classified as normocholesterolemia, HC without statin use, and HC with statin use. Statistical comparisons were performed using Fisher exact test, χ2 tests, and the Breslow-Day test. The discovery cohort consisted of 558 ICH cases and 1444 controls, and the replication cohort consisted of 1020 ICH cases and 382 controls. The association of lower risk for HC was not attenuated by statin use. Statin use was observed to confer a higher risk for lobar ICH in those carrying ApoE4/E4 and ApoE2/E4 genotypes in both discovery and replication cohorts, and a test for interaction showed a trend towards significance (P=0.11 for statin and ApoE4/E4). Statin use does not seem to attenuate the association of HC with decreased risk for nonlobar ICH. Our data support a gene-by-drug effect for lobar ICH, but larger sample sizes are needed to confirm the association before any clinical change is warranted. http://clinicaltrials.gov. Unique identifier: NCT00930280.
Apolipoprotein E (ApoE) genotypes have been associated with lobar intracerebral hemorrhage (ICH). Although statins have been associated with an increased risk of ICH, meta-analyses have not consistently shown a statin-induced risk of ICH. Here, we test whether hypercholesterolemia (HC) and ApoE polymorphisms affect the risk of ICH by statin use.BACKGROUND AND PURPOSEApolipoprotein E (ApoE) genotypes have been associated with lobar intracerebral hemorrhage (ICH). Although statins have been associated with an increased risk of ICH, meta-analyses have not consistently shown a statin-induced risk of ICH. Here, we test whether hypercholesterolemia (HC) and ApoE polymorphisms affect the risk of ICH by statin use.The Genetic and Environmental Risk Factors for Hemorrhagic Stroke (GERFHS) study is a prospective, demographically matched case-control study of ICH. A similar study of ICH, Genetic Risks for Medication-Related Hemorrhagic Stroke (GOCHA), was used as a replication cohort. Subjects were classified as normocholesterolemia, HC without statin use, and HC with statin use. Statistical comparisons were performed using Fisher exact test, χ2 tests, and the Breslow-Day test.METHODSThe Genetic and Environmental Risk Factors for Hemorrhagic Stroke (GERFHS) study is a prospective, demographically matched case-control study of ICH. A similar study of ICH, Genetic Risks for Medication-Related Hemorrhagic Stroke (GOCHA), was used as a replication cohort. Subjects were classified as normocholesterolemia, HC without statin use, and HC with statin use. Statistical comparisons were performed using Fisher exact test, χ2 tests, and the Breslow-Day test.The discovery cohort consisted of 558 ICH cases and 1444 controls, and the replication cohort consisted of 1020 ICH cases and 382 controls. The association of lower risk for HC was not attenuated by statin use. Statin use was observed to confer a higher risk for lobar ICH in those carrying ApoE4/E4 and ApoE2/E4 genotypes in both discovery and replication cohorts, and a test for interaction showed a trend towards significance (P=0.11 for statin and ApoE4/E4).RESULTSThe discovery cohort consisted of 558 ICH cases and 1444 controls, and the replication cohort consisted of 1020 ICH cases and 382 controls. The association of lower risk for HC was not attenuated by statin use. Statin use was observed to confer a higher risk for lobar ICH in those carrying ApoE4/E4 and ApoE2/E4 genotypes in both discovery and replication cohorts, and a test for interaction showed a trend towards significance (P=0.11 for statin and ApoE4/E4).Statin use does not seem to attenuate the association of HC with decreased risk for nonlobar ICH. Our data support a gene-by-drug effect for lobar ICH, but larger sample sizes are needed to confirm the association before any clinical change is warranted.CONCLUSIONSStatin use does not seem to attenuate the association of HC with decreased risk for nonlobar ICH. Our data support a gene-by-drug effect for lobar ICH, but larger sample sizes are needed to confirm the association before any clinical change is warranted.http://clinicaltrials.gov. Unique identifier: NCT00930280.CLINICAL TRIAL REGISTRATION URLhttp://clinicaltrials.gov. Unique identifier: NCT00930280.
Author Falcone, Guido J.
Sauerbeck, Laura
Woo, Jessica G.
Woo, Daniel
Martini, Sharyl R.
Ayres, Alison M.
Rosand, Jonathan
Greenberg, Steven M.
Haverbusch, Mary
Langefeld, Carl D.
Kissela, Brett M.
Flaherty, Matthew L.
Kleindorfer, Dawn O.
Moomaw, Charles J.
Broderick, Joseph P.
Deka, Ranjan
Anderson, Christopher D.
AuthorAffiliation φ Hemorrhagic Stroke Research Group, Massachusetts General Hospital
University of Cincinnati Department of Environmental Health
Wake Forest University, Department of Biostatistical Sciences
Cincinnati Children’s Hospital Medical Center, Division of Biostatistics and Epidemiology
χ Center for Human Genetic Research, Division of Neurocritical Care and Emergency Neurology, Massachusetts General Hospital
γ Program in Medical and Population Genetics, Broad Institute
University of Cincinnati Department of Neurology
AuthorAffiliation_xml – name: χ Center for Human Genetic Research, Division of Neurocritical Care and Emergency Neurology, Massachusetts General Hospital
– name: University of Cincinnati Department of Neurology
– name: Cincinnati Children’s Hospital Medical Center, Division of Biostatistics and Epidemiology
– name: γ Program in Medical and Population Genetics, Broad Institute
– name: Wake Forest University, Department of Biostatistical Sciences
– name: University of Cincinnati Department of Environmental Health
– name: φ Hemorrhagic Stroke Research Group, Massachusetts General Hospital
Author_xml – sequence: 1
  givenname: Daniel
  surname: Woo
  fullname: Woo, Daniel
  organization: From the Departments of Neurology (D.W., M.L.F., M.H., S.R.M., L.S., B.M.K., D.O.K., C.J.M., J.P.B.), and Environmental Health (R.D.), University of Cincinnati, OH; Division of Neurocritical Care and Emergency Neurology (G.J.F., C.D.A., J.R.), and Hemorrhagic Stroke Research Group (G.J.F., S.M.G., A.M.A., C.D.A., J.R.), Department of Neurology, and Center for Human Genetic Research (G.J.F., C.D.A., J.R.), Massachusetts General Hospital, Boston; Program in Medical and Population Genetics, Broad
– sequence: 2
  givenname: Ranjan
  surname: Deka
  fullname: Deka, Ranjan
  organization: From the Departments of Neurology (D.W., M.L.F., M.H., S.R.M., L.S., B.M.K., D.O.K., C.J.M., J.P.B.), and Environmental Health (R.D.), University of Cincinnati, OH; Division of Neurocritical Care and Emergency Neurology (G.J.F., C.D.A., J.R.), and Hemorrhagic Stroke Research Group (G.J.F., S.M.G., A.M.A., C.D.A., J.R.), Department of Neurology, and Center for Human Genetic Research (G.J.F., C.D.A., J.R.), Massachusetts General Hospital, Boston; Program in Medical and Population Genetics, Broad
– sequence: 3
  givenname: Guido J.
  surname: Falcone
  fullname: Falcone, Guido J.
  organization: From the Departments of Neurology (D.W., M.L.F., M.H., S.R.M., L.S., B.M.K., D.O.K., C.J.M., J.P.B.), and Environmental Health (R.D.), University of Cincinnati, OH; Division of Neurocritical Care and Emergency Neurology (G.J.F., C.D.A., J.R.), and Hemorrhagic Stroke Research Group (G.J.F., S.M.G., A.M.A., C.D.A., J.R.), Department of Neurology, and Center for Human Genetic Research (G.J.F., C.D.A., J.R.), Massachusetts General Hospital, Boston; Program in Medical and Population Genetics, Broad
– sequence: 4
  givenname: Matthew L.
  surname: Flaherty
  fullname: Flaherty, Matthew L.
  organization: From the Departments of Neurology (D.W., M.L.F., M.H., S.R.M., L.S., B.M.K., D.O.K., C.J.M., J.P.B.), and Environmental Health (R.D.), University of Cincinnati, OH; Division of Neurocritical Care and Emergency Neurology (G.J.F., C.D.A., J.R.), and Hemorrhagic Stroke Research Group (G.J.F., S.M.G., A.M.A., C.D.A., J.R.), Department of Neurology, and Center for Human Genetic Research (G.J.F., C.D.A., J.R.), Massachusetts General Hospital, Boston; Program in Medical and Population Genetics, Broad
– sequence: 5
  givenname: Mary
  surname: Haverbusch
  fullname: Haverbusch, Mary
  organization: From the Departments of Neurology (D.W., M.L.F., M.H., S.R.M., L.S., B.M.K., D.O.K., C.J.M., J.P.B.), and Environmental Health (R.D.), University of Cincinnati, OH; Division of Neurocritical Care and Emergency Neurology (G.J.F., C.D.A., J.R.), and Hemorrhagic Stroke Research Group (G.J.F., S.M.G., A.M.A., C.D.A., J.R.), Department of Neurology, and Center for Human Genetic Research (G.J.F., C.D.A., J.R.), Massachusetts General Hospital, Boston; Program in Medical and Population Genetics, Broad
– sequence: 6
  givenname: Sharyl R.
  surname: Martini
  fullname: Martini, Sharyl R.
  organization: From the Departments of Neurology (D.W., M.L.F., M.H., S.R.M., L.S., B.M.K., D.O.K., C.J.M., J.P.B.), and Environmental Health (R.D.), University of Cincinnati, OH; Division of Neurocritical Care and Emergency Neurology (G.J.F., C.D.A., J.R.), and Hemorrhagic Stroke Research Group (G.J.F., S.M.G., A.M.A., C.D.A., J.R.), Department of Neurology, and Center for Human Genetic Research (G.J.F., C.D.A., J.R.), Massachusetts General Hospital, Boston; Program in Medical and Population Genetics, Broad
– sequence: 7
  givenname: Steven M.
  surname: Greenberg
  fullname: Greenberg, Steven M.
  organization: From the Departments of Neurology (D.W., M.L.F., M.H., S.R.M., L.S., B.M.K., D.O.K., C.J.M., J.P.B.), and Environmental Health (R.D.), University of Cincinnati, OH; Division of Neurocritical Care and Emergency Neurology (G.J.F., C.D.A., J.R.), and Hemorrhagic Stroke Research Group (G.J.F., S.M.G., A.M.A., C.D.A., J.R.), Department of Neurology, and Center for Human Genetic Research (G.J.F., C.D.A., J.R.), Massachusetts General Hospital, Boston; Program in Medical and Population Genetics, Broad
– sequence: 8
  givenname: Alison M.
  surname: Ayres
  fullname: Ayres, Alison M.
  organization: From the Departments of Neurology (D.W., M.L.F., M.H., S.R.M., L.S., B.M.K., D.O.K., C.J.M., J.P.B.), and Environmental Health (R.D.), University of Cincinnati, OH; Division of Neurocritical Care and Emergency Neurology (G.J.F., C.D.A., J.R.), and Hemorrhagic Stroke Research Group (G.J.F., S.M.G., A.M.A., C.D.A., J.R.), Department of Neurology, and Center for Human Genetic Research (G.J.F., C.D.A., J.R.), Massachusetts General Hospital, Boston; Program in Medical and Population Genetics, Broad
– sequence: 9
  givenname: Laura
  surname: Sauerbeck
  fullname: Sauerbeck, Laura
  organization: From the Departments of Neurology (D.W., M.L.F., M.H., S.R.M., L.S., B.M.K., D.O.K., C.J.M., J.P.B.), and Environmental Health (R.D.), University of Cincinnati, OH; Division of Neurocritical Care and Emergency Neurology (G.J.F., C.D.A., J.R.), and Hemorrhagic Stroke Research Group (G.J.F., S.M.G., A.M.A., C.D.A., J.R.), Department of Neurology, and Center for Human Genetic Research (G.J.F., C.D.A., J.R.), Massachusetts General Hospital, Boston; Program in Medical and Population Genetics, Broad
– sequence: 10
  givenname: Brett M.
  surname: Kissela
  fullname: Kissela, Brett M.
  organization: From the Departments of Neurology (D.W., M.L.F., M.H., S.R.M., L.S., B.M.K., D.O.K., C.J.M., J.P.B.), and Environmental Health (R.D.), University of Cincinnati, OH; Division of Neurocritical Care and Emergency Neurology (G.J.F., C.D.A., J.R.), and Hemorrhagic Stroke Research Group (G.J.F., S.M.G., A.M.A., C.D.A., J.R.), Department of Neurology, and Center for Human Genetic Research (G.J.F., C.D.A., J.R.), Massachusetts General Hospital, Boston; Program in Medical and Population Genetics, Broad
– sequence: 11
  givenname: Dawn O.
  surname: Kleindorfer
  fullname: Kleindorfer, Dawn O.
  organization: From the Departments of Neurology (D.W., M.L.F., M.H., S.R.M., L.S., B.M.K., D.O.K., C.J.M., J.P.B.), and Environmental Health (R.D.), University of Cincinnati, OH; Division of Neurocritical Care and Emergency Neurology (G.J.F., C.D.A., J.R.), and Hemorrhagic Stroke Research Group (G.J.F., S.M.G., A.M.A., C.D.A., J.R.), Department of Neurology, and Center for Human Genetic Research (G.J.F., C.D.A., J.R.), Massachusetts General Hospital, Boston; Program in Medical and Population Genetics, Broad
– sequence: 12
  givenname: Charles J.
  surname: Moomaw
  fullname: Moomaw, Charles J.
  organization: From the Departments of Neurology (D.W., M.L.F., M.H., S.R.M., L.S., B.M.K., D.O.K., C.J.M., J.P.B.), and Environmental Health (R.D.), University of Cincinnati, OH; Division of Neurocritical Care and Emergency Neurology (G.J.F., C.D.A., J.R.), and Hemorrhagic Stroke Research Group (G.J.F., S.M.G., A.M.A., C.D.A., J.R.), Department of Neurology, and Center for Human Genetic Research (G.J.F., C.D.A., J.R.), Massachusetts General Hospital, Boston; Program in Medical and Population Genetics, Broad
– sequence: 13
  givenname: Christopher D.
  surname: Anderson
  fullname: Anderson, Christopher D.
  organization: From the Departments of Neurology (D.W., M.L.F., M.H., S.R.M., L.S., B.M.K., D.O.K., C.J.M., J.P.B.), and Environmental Health (R.D.), University of Cincinnati, OH; Division of Neurocritical Care and Emergency Neurology (G.J.F., C.D.A., J.R.), and Hemorrhagic Stroke Research Group (G.J.F., S.M.G., A.M.A., C.D.A., J.R.), Department of Neurology, and Center for Human Genetic Research (G.J.F., C.D.A., J.R.), Massachusetts General Hospital, Boston; Program in Medical and Population Genetics, Broad
– sequence: 14
  givenname: Joseph P.
  surname: Broderick
  fullname: Broderick, Joseph P.
  organization: From the Departments of Neurology (D.W., M.L.F., M.H., S.R.M., L.S., B.M.K., D.O.K., C.J.M., J.P.B.), and Environmental Health (R.D.), University of Cincinnati, OH; Division of Neurocritical Care and Emergency Neurology (G.J.F., C.D.A., J.R.), and Hemorrhagic Stroke Research Group (G.J.F., S.M.G., A.M.A., C.D.A., J.R.), Department of Neurology, and Center for Human Genetic Research (G.J.F., C.D.A., J.R.), Massachusetts General Hospital, Boston; Program in Medical and Population Genetics, Broad
– sequence: 15
  givenname: Jonathan
  surname: Rosand
  fullname: Rosand, Jonathan
  organization: From the Departments of Neurology (D.W., M.L.F., M.H., S.R.M., L.S., B.M.K., D.O.K., C.J.M., J.P.B.), and Environmental Health (R.D.), University of Cincinnati, OH; Division of Neurocritical Care and Emergency Neurology (G.J.F., C.D.A., J.R.), and Hemorrhagic Stroke Research Group (G.J.F., S.M.G., A.M.A., C.D.A., J.R.), Department of Neurology, and Center for Human Genetic Research (G.J.F., C.D.A., J.R.), Massachusetts General Hospital, Boston; Program in Medical and Population Genetics, Broad
– sequence: 16
  givenname: Carl D.
  surname: Langefeld
  fullname: Langefeld, Carl D.
  organization: From the Departments of Neurology (D.W., M.L.F., M.H., S.R.M., L.S., B.M.K., D.O.K., C.J.M., J.P.B.), and Environmental Health (R.D.), University of Cincinnati, OH; Division of Neurocritical Care and Emergency Neurology (G.J.F., C.D.A., J.R.), and Hemorrhagic Stroke Research Group (G.J.F., S.M.G., A.M.A., C.D.A., J.R.), Department of Neurology, and Center for Human Genetic Research (G.J.F., C.D.A., J.R.), Massachusetts General Hospital, Boston; Program in Medical and Population Genetics, Broad
– sequence: 17
  givenname: Jessica G.
  surname: Woo
  fullname: Woo, Jessica G.
  organization: From the Departments of Neurology (D.W., M.L.F., M.H., S.R.M., L.S., B.M.K., D.O.K., C.J.M., J.P.B.), and Environmental Health (R.D.), University of Cincinnati, OH; Division of Neurocritical Care and Emergency Neurology (G.J.F., C.D.A., J.R.), and Hemorrhagic Stroke Research Group (G.J.F., S.M.G., A.M.A., C.D.A., J.R.), Department of Neurology, and Center for Human Genetic Research (G.J.F., C.D.A., J.R.), Massachusetts General Hospital, Boston; Program in Medical and Population Genetics, Broad
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27863424$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/24008570$$D View this record in MEDLINE/PubMed
BookMark eNp9kUtPHDEQhK2IKCwk_yCK5hKJAwN-9LxyCFqhJYtAQgJytno8PeBk1p7Ys5Hy7_FqF_I45GS1_FV1qeuA7TnviLH3gp8IUYrTu_vbm6vFfDlPozrhXCgOr9hMFBJyKGW9x2acqyaX0DT77CDGb5xzqeriDduXwHldVHzGzuajH-zox-Ansi5bHGd3E07WxeMMXZfd2vg983126aaAhgK1AYdsSSsfwiM-0Fv2usch0rvde8i-Xizuz5f59c2Xy_P5dW5A1VMOLcmqazk0pcAK-o4aVRohqZEopeSdKdoCoeoEFXXXYwqojOoU1U0PKEkdss9b33HdrqgztMkz6DHYFYZf2qPVf_84-6gf_E-t6kpVokoGRzuD4H-sKU56ZaOhYUBHfh21AADVKF6XCf3w566XJc9XS8DHHYDR4NAHdMbG31yVTEBC4j5tORN8jIF6bezmuH4T0Q5acL2pUr9UmUalt1UmMfwjfvb_r-wJUbWiJA
CODEN SJCCA7
CitedBy_id crossref_primary_10_1212_WNL_0000000000200851
crossref_primary_10_7759_cureus_33236
crossref_primary_10_1002_ana_26426
crossref_primary_10_1212_WNL_0000000000001790
crossref_primary_10_1212_NXG_0000000000000081
crossref_primary_10_1016_j_ejphar_2025_177443
crossref_primary_10_2174_1570161119666211109122231
crossref_primary_10_1136_jnnp_2015_312736
crossref_primary_10_1007_s40256_018_0301_4
crossref_primary_10_1159_000538195
crossref_primary_10_12677_ACM_2023_134984
crossref_primary_10_1007_s11883_015_0526_5
crossref_primary_10_1016_j_pjnns_2015_07_007
crossref_primary_10_1371_journal_pone_0171379
crossref_primary_10_1093_brain_awac259
crossref_primary_10_1080_23808993_2020_1738217
crossref_primary_10_1002_pds_3817
crossref_primary_10_5937_Galmed2204109Z
crossref_primary_10_1007_s11011_015_9737_2
crossref_primary_10_1212_WNL_0000000000003281
crossref_primary_10_1097_MD_0000000000030782
crossref_primary_10_1186_s13024_023_00640_5
crossref_primary_10_1136_jnnp_2016_314697
crossref_primary_10_1161_ATV_0000000000000164
crossref_primary_10_1007_s11910_016_0621_1
crossref_primary_10_1038_s41598_018_20055_3
crossref_primary_10_1161_STROKEAHA_122_036889
crossref_primary_10_1161_STROKEAHA_117_019141
crossref_primary_10_1002_ajmg_b_33010
crossref_primary_10_1016_j_jamda_2018_05_025
crossref_primary_10_1161_STROKEAHA_117_019322
crossref_primary_10_30629_2658_7947_2019_24_6_29_38
crossref_primary_10_1007_s11596_019_2007_5
crossref_primary_10_1016_j_jstrokecerebrovasdis_2023_107268
crossref_primary_10_1161_STR_0000000000000407
crossref_primary_10_1016_j_jns_2020_117224
crossref_primary_10_3760_cma_j_issn_0366_6999_20140574
crossref_primary_10_1007_s11886_021_01594_0
Cites_doi 10.1253/jcj.40.723
10.1161/01.str.0000160756.72109.95
10.3171/jns.1997.86.4.0583
10.1161/01.ATV.11.5.1237
10.1161/01.STR.20.11.1460
10.1161/STROKEAHA.108.533190
10.1212/WNL.43.8.1467
10.1161/strokeaha.112.655894
10.1016/S0304-3940(98)00286-9
10.1161/01.ATV.11.2.290
10.1126/science.1220725
10.1016/0896-6273(93)90070-8
10.1001/archneurol.2010.356
10.1161/01.STR.19.1.48
10.1212/WNL.0b013e318276896f
10.1007/BF03170486
10.1161/01.str.0000110982.74967.39
10.1038/ng0694-180
10.1161/01.str.0000014774.88027.22
10.1002/ana.410380219
10.1161/01.str.0000127786.16612.a4
10.1054/jocn.2002.1111
10.1212/01.wnl.0000296277.63350.77
ContentType Journal Article
Copyright 2014 INIST-CNRS
Copyright_xml – notice: 2014 INIST-CNRS
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1161/STROKEAHA.113.001304
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1524-4628
EndPage 3017
ExternalDocumentID PMC3873717
24008570
27863424
10_1161_STROKEAHA_113_001304
Genre Journal Article
Observational Study
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NINDS NIH HHS
  grantid: R01 NS036695
– fundername: NINDS NIH HHS
  grantid: R-01-NS 36695
– fundername: NINDS NIH HHS
  grantid: U01 NS036695
– fundername: NINDS NIH HHS
  grantid: U01 NS069763
– fundername: NIEHS NIH HHS
  grantid: P30 ES006096
– fundername: NIEHS NIH HHS
  grantid: R-01-ES 06096
– fundername: NINDS NIH HHS
  grantid: R01 NS059727
– fundername: NINDS NIH HHS
  grantid: R01NS059727
– fundername: NCATS NIH HHS
  grantid: UL1 TR000077
– fundername: NCRR NIH HHS
  grantid: M01 RR000042
– fundername: National Institute of Neurological Disorders and Stroke : NINDS
  grantid: R01 NS036695 || NS
GroupedDBID ---
.3C
.55
.GJ
.XZ
.Z2
01R
0R~
123
1J1
2WC
3O-
40H
4Q1
4Q2
4Q3
53G
5RE
5VS
6PF
71W
77Y
7O~
A9M
AAAAV
AAAXR
AAGIX
AAHPQ
AAIQE
AAJCS
AAMOA
AAMTA
AAQKA
AAQQT
AARTV
AASCR
AASOK
AAUEB
AAXQO
AAYEP
AAYJJ
AAYXX
ABASU
ABBUW
ABDIG
ABJNI
ABPXF
ABQRW
ABVCZ
ABXVJ
ABXYN
ABZAD
ABZZY
ACCJW
ACDDN
ACDOF
ACEWG
ACGFS
ACGOD
ACILI
ACLDA
ACWDW
ACWRI
ACXJB
ACXNZ
ACZKN
ADBBV
ADFPA
ADGGA
ADGHP
ADHPY
ADNKB
AE3
AE6
AEBDS
AEETU
AENEX
AFBFQ
AFDTB
AFEXH
AFFNX
AFMBP
AFNMH
AFSOK
AFUWQ
AGINI
AHMBA
AHOMT
AHQNM
AHQVU
AHRYX
AHVBC
AIJEX
AINUH
AJCLO
AJIOK
AJNWD
AJNYG
AJZMW
AKCTQ
AKULP
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
AYCSE
BAWUL
BCGUY
BOYCO
BQLVK
BS7
C45
CITATION
CS3
DIK
DIWNM
DU5
DUNZO
E.X
E3Z
EBS
EEVPB
EJD
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FL-
FW0
GNXGY
GQDEL
GX1
H0~
H13
HLJTE
HZ~
IKREB
IKYAY
IN~
IPNFZ
J5H
JF9
JG8
JK3
JK8
K8S
KD2
KMI
KQ8
L-C
L7B
M18
N4W
N9A
N~7
N~B
N~M
O9-
OAG
OAH
OB3
OCUKA
ODA
ODMTH
OGROG
OHYEH
OK1
OL1
OLG
OLH
OLU
OLV
OLY
OLZ
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OVIDH
OVLEI
OVOZU
OWBYB
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P-K
P2P
PQQKQ
R58
RAH
RIG
RLZ
S4R
S4S
T8P
TEORI
TSPGW
V2I
VVN
W3M
W8F
WH7
WOQ
WOW
X3V
X3W
X7M
XXN
XYM
YFH
YHZ
YQJ
YYP
ZB8
ZGI
ZZMQN
IQODW
ACIJW
CGR
CUY
CVF
ECM
EIF
NPM
YCJ
7X8
5PM
ID FETCH-LOGICAL-c438t-4be27db04961a74fde936c12e92a2220dc5b5a47d1e58dfa2403c3d3e89f4a2e3
ISSN 0039-2499
1524-4628
IngestDate Thu Aug 21 18:11:44 EDT 2025
Fri Jul 11 03:05:21 EDT 2025
Thu Apr 03 07:06:17 EDT 2025
Mon Jul 21 09:16:54 EDT 2025
Tue Jul 01 03:31:38 EDT 2025
Thu Apr 24 23:08:52 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords Stroke
Nervous system diseases
Enzyme
Cardiovascular disease
Statin derivative
Epidemiology
Cerebral disorder
Vascular disease
intracerebral hemorrhage
genetics
pharmacogenomics
Apolipoprotein E
Cerebral hemorrhage
Central nervous system disease
Risk factor
Oxidoreductases
hydroxymethylgutaryl-CoA reductase inhibitors
Cerebrovascular disease
Antilipemic agent
Reductase
apolipoprotein E
epidemiology
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c438t-4be27db04961a74fde936c12e92a2220dc5b5a47d1e58dfa2403c3d3e89f4a2e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
OpenAccessLink https://www.ahajournals.org/doi/pdf/10.1161/STROKEAHA.113.001304
PMID 24008570
PQID 1444393086
PQPubID 23479
PageCount 5
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3873717
proquest_miscellaneous_1444393086
pubmed_primary_24008570
pascalfrancis_primary_27863424
crossref_citationtrail_10_1161_STROKEAHA_113_001304
crossref_primary_10_1161_STROKEAHA_113_001304
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2013-11-01
PublicationDateYYYYMMDD 2013-11-01
PublicationDate_xml – month: 11
  year: 2013
  text: 2013-11-01
  day: 01
PublicationDecade 2010
PublicationPlace Hagerstown, MD
PublicationPlace_xml – name: Hagerstown, MD
– name: United States
PublicationTitle Stroke (1970)
PublicationTitleAlternate Stroke
PublicationYear 2013
Publisher Lippincott Williams & Wilkins
Publisher_xml – name: Lippincott Williams & Wilkins
References e_1_3_3_6_2
e_1_3_3_5_2
e_1_3_3_8_2
Jacobs DR (e_1_3_3_7_2) 1994; 6
e_1_3_3_17_2
e_1_3_3_9_2
e_1_3_3_16_2
e_1_3_3_19_2
e_1_3_3_18_2
e_1_3_3_13_2
e_1_3_3_24_2
e_1_3_3_12_2
e_1_3_3_23_2
e_1_3_3_15_2
e_1_3_3_14_2
e_1_3_3_25_2
e_1_3_3_2_2
e_1_3_3_20_2
e_1_3_3_4_2
e_1_3_3_11_2
e_1_3_3_22_2
e_1_3_3_3_2
e_1_3_3_10_2
e_1_3_3_21_2
References_xml – ident: e_1_3_3_4_2
  doi: 10.1253/jcj.40.723
– ident: e_1_3_3_16_2
  doi: 10.1161/01.str.0000160756.72109.95
– ident: e_1_3_3_3_2
  doi: 10.3171/jns.1997.86.4.0583
– ident: e_1_3_3_22_2
  doi: 10.1161/01.ATV.11.5.1237
– ident: e_1_3_3_6_2
  doi: 10.1161/01.STR.20.11.1460
– ident: e_1_3_3_15_2
  doi: 10.1161/STROKEAHA.108.533190
– ident: e_1_3_3_21_2
  doi: 10.1212/WNL.43.8.1467
– ident: e_1_3_3_12_2
  doi: 10.1161/strokeaha.112.655894
– ident: e_1_3_3_19_2
  doi: 10.1016/S0304-3940(98)00286-9
– ident: e_1_3_3_24_2
  doi: 10.1161/01.ATV.11.2.290
– ident: e_1_3_3_25_2
  doi: 10.1126/science.1220725
– ident: e_1_3_3_17_2
  doi: 10.1016/0896-6273(93)90070-8
– ident: e_1_3_3_13_2
  doi: 10.1001/archneurol.2010.356
– ident: e_1_3_3_5_2
  doi: 10.1161/01.STR.19.1.48
– ident: e_1_3_3_10_2
  doi: 10.1212/WNL.0b013e318276896f
– ident: e_1_3_3_23_2
  doi: 10.1007/BF03170486
– ident: e_1_3_3_2_2
  doi: 10.1161/01.str.0000110982.74967.39
– ident: e_1_3_3_20_2
  doi: 10.1038/ng0694-180
– ident: e_1_3_3_14_2
  doi: 10.1161/01.str.0000014774.88027.22
– ident: e_1_3_3_18_2
  doi: 10.1002/ana.410380219
– volume: 6
  start-page: 87
  year: 1994
  ident: e_1_3_3_7_2
  article-title: The relationship between cholesterol and stroke.
  publication-title: Health Rep
– ident: e_1_3_3_9_2
  doi: 10.1161/01.str.0000127786.16612.a4
– ident: e_1_3_3_8_2
  doi: 10.1054/jocn.2002.1111
– ident: e_1_3_3_11_2
  doi: 10.1212/01.wnl.0000296277.63350.77
SSID ssj0002385
Score 2.3086982
Snippet Apolipoprotein E (ApoE) genotypes have been associated with lobar intracerebral hemorrhage (ICH). Although statins have been associated with an increased risk...
SourceID pubmedcentral
proquest
pubmed
pascalfrancis
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 3013
SubjectTerms Aged
Apolipoproteins E - genetics
Apolipoproteins E - metabolism
Biological and medical sciences
Case-Control Studies
Cerebral Hemorrhage - chemically induced
Cerebral Hemorrhage - diagnosis
Cerebral Hemorrhage - genetics
Drug toxicity and drugs side effects treatment
Female
Genotype
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects
Male
Medical sciences
Middle Aged
Neurology
Pharmacology. Drug treatments
Prospective Studies
Risk Factors
Toxicity: nervous system and muscle
Vascular diseases and vascular malformations of the nervous system
Title Apolipoprotein E, Statins, and Risk of Intracerebral Hemorrhage
URI https://www.ncbi.nlm.nih.gov/pubmed/24008570
https://www.proquest.com/docview/1444393086
https://pubmed.ncbi.nlm.nih.gov/PMC3873717
Volume 44
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBASQlxHB0xB4q1LSGwnTp5QhTrKxkCwTuytsmNHLWNJlaUviB_PcezmMlXAeImaxLGSfp-Pz7HPBaHXKlRZEmYJIBBpAyXzXS5gPAJfQgkaAU6xjh0--RRNz-jReXg-GPzqRpdUwkt_bo0r-R9U4RrgqqNkb4Bs0ylcgN-ALxwBYTj-E8ZjXWJhVdS5Fpb5aGLctuCmUY7r2EPrOv5BL-KmqtT7xDqd8GVRlgvedwQ6rcriotY5g4T5nTWCb0XRhqM3qq-6MIonz7-3FDvkeoerXiV9v17KYnTktRThC53J14QI1WXGRx-97rJDQGz8XUeUEr01Y6obecpKT0xdHezaFa8mveOGRkFHWIJsIZ2JF07ZdqEeaaF-Ovv6-Xgyno51GRqv3nGl7SS22bi_Nrc1Hoe1rRMF86YXOCVz08stdBuDkaHrXxx_aXPNgzJj6l_YD7WBl9DLm23v0lNs7q34FYyxzBRH2Wa9XHfC7Wg1swfovjVHnLHh1kM0UPkjdOfEOlw8Rm_7FHMmB44l2IED9HI0vZwic3r0clp6PUFnh5PZu6lra264KSVx5VKhMJMC7MYo4IxmUiUkSgOsEsxBlfRlGoqQUyYDFcYy4zqdY0okUXGSUY4VeYp2cqDZM-SA4iplKAMd_E1FFsVY-CLK_IALQkKJh4hs_rB5ahPS67ooP-Z_AmuI3OaplUnI8pf2-z0smocwiyNCMTR4tQFnDqJV75fxXBXrK7CKKajrBIz-Ido1YLVPU1MbYohYD8amgU7b3r-TLxd1-nYSM8ICtnfDD3mO7rbj8AXaqcq1egkKcSX2a97-BqqurCE
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Apolipoprotein+E%2C+Statins%2C+and+Risk+of+Intracerebral+Hemorrhage&rft.jtitle=Stroke+%281970%29&rft.au=Woo%2C+Daniel&rft.au=Deka%2C+Ranjan&rft.au=Falcone%2C+Guido+J.&rft.au=Flaherty%2C+Matthew+L.&rft.date=2013-11-01&rft.issn=0039-2499&rft.eissn=1524-4628&rft.volume=44&rft.issue=11&rft.spage=3013&rft.epage=3017&rft_id=info:doi/10.1161%2FSTROKEAHA.113.001304&rft.externalDBID=n%2Fa&rft.externalDocID=10_1161_STROKEAHA_113_001304
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0039-2499&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0039-2499&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0039-2499&client=summon